Epithelial membrane antigen in hematolymphoid neoplasms: A review

Applied Immunohistochemistry and Molecular Morphology

Volumn 5, Issue 4, 1997, Pages 203-215

  Chittal, Shashikant ^b   Al Saati, Talal ^a   Delsol, Georges ^a  

^a CHU PURPAN   (France)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Anaplastic large cell lymphoma; Epithelial membrane antigen (EMA); Hodgkin's disease; Immunohistochemistry; MUC1 mucin; Non Hodgkin's lymphoma

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN;

B CELL LYMPHOMA; CHROMOSOME 1Q; HEMATOPOIETIC TISSUE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHATIC SYSTEM TUMOR; MYELOPROLIFERATIVE DISORDER; NODULAR LYMPHOMATOSIS; NONHODGKIN LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW; T CELL LYMPHOMA;

EID: 0031430069     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199712000-00001     Document Type: Review

References (151)

1. Gum JR, Mucin genes and proteins they encode: structure, diversity, and regulation Am J Respir Cell Mol Biol 1992;7:557-64.
2. Jass JR, Roberton AM. Colorectal mucin histochemistry in health and disease: a critical review. Pathol Int 1994;44:487-504.
3. Ceriani RL, Thompson K, Peterson JA, Abraham S. Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc Natl Acad Sci USA 1977; 74:582-6.
4. Heyderman E, Steele K, Ormerod MG. A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue. J Clin Pathol 1979;32:35-9.
5. Sloane JP, Ormerod MG, Neville AM. Potential pathological application of immunocytochemical methods to the detection of micrometastases. Cancer Res 1980; 40:3079-82.
6. Dearnaley DP, Ormerod MG, Sloane JP, et al. Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J Roy Soc Med 1983;76:359-64.
7. Heyderman E, Graham RM, Chapman DV, Richardson TC, McKee PH. Epithelial markers in primary skin cancer: an immunoperoxidase study of the distribution of epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) in 65 primary skin carcinomas. Histopathology 1984;8:423-34.
8. Sloane JP, Hughes F, Ormerod MG. An assessment of the value of epithelial membrane antigen and other epithelial markers in solving diagnostic problems in tumour histopathology. Histochem J 1983;15:645-54.
9. Heyderman E, Macartney JC. Epithelial membrane antigen and lymphoid cells. Lancet 1985;1:109.
10. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 1981;28:17-21.
11. Shimizu M, Yamauchi K. Isolation and characterization of mucin-like glycoprotein in human milk fat globule membrane. J Biochem 1982;91:515-24.
12. Ormerod MG, Steele K, Westwood JH, Mazzini MN. Epithelial membrane antigen: partial purification, assay and properties. Int J Cancer 1983;48:533-41.
13. Hilkens J, Buijs F, Hilgers J, et al. Monoclonal antibodies against human milk-fat globule membrane detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984; 34:197-206.
14. Hilkens J, Buijs F. Biosynthesis of MAM-6, an epithelial sialomucin. J Biol Chem 1988;263:4215-22.
15. Hilkens J, Buijs F, Ligtenberg M. Complexity of MAM-6, an epithelial sialomucin associated with carcinomas. Cancer Res 1989;49:786-93.
16. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 1988;263:12820-23.
17. Hayes DF, Zurawski VR, Kufe DW. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 1986;4:1542-50.
18. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984;3:223-32.
19. Peterson JA, Zava DT, Duwe AK, Blank EW, Battifora H, Ceriani RL. Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule. Hybridoma 1990;9:221-35.
20. Peterson JA, Couto JR, Taylor MR, Ceriani RL. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy. Cancer Res 1995;55:5847S-51S.
21. Gatter KC, Abdulaziz Z, Beverley P, et al. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 1982;35:1253-67.
22. Delsol G, Gatter KC, Stein H, et al. Human lymphoid cells express epithelial membrane antigen. Lancet 1984;2:1124-29.
23. Cordell J, Richardson TC, Pulford KAF, et al. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 1985;52:347-54.
24. Litvinov SV, Hilkens J. The epithelial sialomucin, episialin, is sialylated during recycling. J Biol Chem 1993;268:21364-71.
25. McGuckin MA, Walsh MD, Hohn BG, Ward BG, Wright RG. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 1995;26:432-9.
26. Ligtenberg MJL, Vos HL, Gennissen AMC, Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 1990;265:5573-8.
27. Wreschner DH, Hareuveni M, Tsarfaty I, et al. Human epithelial tumor antigen cDNA sequences: differential splicing may generate multiple forms. Eur J Biochem 1990;189:463-73.
28. Lan MS, Batra SK, Qi WN, Metzgar RS, Hollingsworth MA. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 1990;265:15294-99.
29. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265:15286-93.
30. Ajioka Y, Allison L, Jass JR. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol 1996;49: 560-4.
31. Swallow DM, Gendler S, Griffiths B, Corney G, Taylor-Papadimitriou J, Bramwell ME. The human tumor-associated epithelial mucin are coded by an expressed hypervariable gene locus PUM. Nature 1987;328:82-4.
32. Swallow DM, Gendler S, Griffiths B, et al. The hypervariable gene locus PUM, which codes for the tumor-associated epithelial mucins, is located on chromosome 1 within the region 1q21-24 [abstract]. From the 9th International Workshop on Human Gene Mapping. Cytogenet Cell Genet 1987;46:701.
33. Griffiths B, Gum J, West LF, Povey S, Swallow DM, Kim YS. Mapping of the gene coding for intestinal mucin to chromosome 11p15 [abstract]. From the 10th International Workshop on Human Gene Mapping. Cytogenet Cell Genet 1989;51:1008.
34. Siddiqui J, Abe M, Hayes D, Shani E, Yunis E, Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 1988;85: 2320-23.
35. Fontenot JD, Tjandra N, Bu D, Ho C, Montelaro RC, Finn OJ. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core. Cancer Res 1993; 53:5386-94.
36. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUCl) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-65.
37. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996;7: 565-77.
38. Becker JW, Erickson HP, Hoffman S, Cunningham BA, Edelman GM. Topology of cell adhesion molecules. Proc Natl Acad Sci USA 1989;86:1088-92.
39. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
40. Lancaster CA, Peat N, Duhig T, Wilson D, Taylor-Papadimitriou J, Gendler S. Structure and expression of the human polymorphic mucin gene: an expressed VNTR unit. Biochem Biophys Res Commun 1990;173:1019-29.
41. Xing PX, Tjandra JJ, Reynolds K, McLaughlin PJ, Purcell DFJ, McKenzie IFC. Reactivity of anti-human milk fat globule antibodies with synthetic peptides. J Immunol 1989;142:3503-9.
42. Xing PX, Reynolds K, Tjandra JJ, Tang XL, McKenzie IFC. Synthetic peptides Reactive with anti-human milk fat globule membrane monoclonal antibodies. Cancer Res 1990;50:89-96.
43. Zaretsky JZ, Weiss M, Tsarfaty I, Hareuveni M, Wreschner DH, Keydar I. Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen: a comparative analysis in breast cancer. FEBS Lett 1990;265:46-50.
44. Hilkens J, Ligtenberg MJL, Vos HL, Litvinov SV. Cell membrane-associated mucins and their adhesion-modulating property. TIBS 1992;17:359-63.
45. Ligtenberg MJL, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res 1992; 52:2318-24.
46. Vleminchx K, Vakaet L Jr, Mareel M, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66: 107-19.
47. Barnd DL, Lan MS, Metzgar RS, Finn OJ. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 1989;86:7159-63.
48. Jerome KR, Barnd DL, Bendt KM, et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope of the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 1991;51: 2908-16.
49. Domenech N, Finn OJ. In vitro studies of MHC-restricted recognition of a peptide from the MUC1 tandem repeat by CTL. FASEB J 1995;9:A1023.
50. Gimmi CD, Morrison BW, Mainprice BA, et al. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature Med 1996;2:1367-70.
51. Heyderman E, Strudley I, Powell G, Richardson TC, Cordell JL. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29: a comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. Br J Cancer 1985;52:355-61.
52. Delsol G, Al Saati T, Gatter KC, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value of so-called "malignant histiocytosis." Am J Pathol 1988;130:59-70.
53. Imrie SF, Sloane JP, Ormerod MG, Styles J, Dean CJ. Detailed investigation of the diagnostic value in tumour histopathlogy of ICR.2, a new monoclonal antibody to epithelial membrane anti7 gen. Histopathology 1990;16:573-81.
54. Pinkus GS, Kurtin PJ. Epithelial membrane antigen - a diagnostic discriminant in surgical pathology: immunohistochemical profile in epthelial, mesenchymal, and hematopoietic neoplasm using paraffin sections and monoclonal antibodies. Hum Pathol 1985; 16:929-10.
55. Stein H, Hansmann M-L, Lennert K, Brandtzaeg P, Gatter KC, Mason DY. Reed-Sternberg and Hodgkin cells in lymphocyte predominant Hodgkin's disease of nodular subtype contain J-chain. Am J Clin Pathol 1986;86:292-7.
56. Jack AS, Cunningham D, Soukop M, Liddle CN, Lee FD. Use of Leu-M1 anti epithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease. J Clin Pathol 1986; 39: 267-70.
57. Baden E, Al Saati T, Caverivière P, Gorguet B, Delsol G. Hodgkin's lymphomas of the oropharyngeal region: report of four cases and diagnostic value of monoclonal antibodies detecting Reed-Sternberg cell-associated antigens. Oral Surg Oral Med Oral Pathol 1987;64:88-94.
58. Strickler JG, Weiss LM, Copenhaver CM, et al. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas. Hum Pathol 1987;18:808-14.
59. Thomas P, Battifora H. Keratins versus epithelial membrane antigen in tumor diagnosis: an immunohistochemical comparison of five monoclonal antibodies. Hum Pathol 1987;18:728-34.
60. Chittal SM, Caveriviere P, Schwarting R, et al. Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search for a rational panel. Am J Surg Pathol 1988;12:9-21.
61. Fujimoto J, Hata J, Ishii E, et al. Ki-1 lymphomas in childhood: immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker. Virchows Arch A Pathol Anat Histopathol 1988;412:307-14.
62. Hall PA, D'Ardenne AJ, Stansfeld AG. Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Ki-1) lymphoma. Histopathology 1988;13:161-9.
63. Sundeen JT, Cossman J, Jaffe ES. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent large cell lymphoma: histological progression or composite malignancy? Am J Surg Pathol 1988;12:599-606.
64. Chittal SM, Alard C, Rossi JF, et al. Further phenotypic evidence that nodular lymphocyte predominance Hodgkin's disease is a large B-cell lymphoma in evolution. Am J Surg Pathol 1990;14: 1024-35.
65. Leoncini L, Del Vecchio MT, Kraft R, et al. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas - a continuous spectrum of malignant disorders. Am J Pathol 1990;137: 1047-57.
66. de Mascarel I, Trojani M, Eghbali H, Coindre J-M, Bonichon F. Prognostic value of phenotyping by Ber-H2, Leu-M1, EMA in Hodgkin's disease. Arch Pathol Lab Med 1990;114:953-5.
67. Sarkar AB, Akagi T, Yoshino T, Hoshida Y, Takahashi K, Hone Y. Expression of vimentin and epithelial membrane antigen in human malignant lymphomas. Acta Pathol Jpn 1990;40:581-7.
68. Carbone A, Gloghini A, Volpe R. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas. Virchows Arch A Pathol Anat 1992;420:527-32.
69. Carbone A, Gloghini A, Volpe R. Immunohistochemistry of Hodgkin and nonHodgkin lymphomas with emphasis on the diagnostic significance of the BNH.9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Cancer 1992;70: 2691-8.
70. Tosi P, Leoncini L, Del Vecchio MT, et al. Phenotypic overlaps between pleomorphic malignant T-cell lymphomas and mixed-cellularity Hodgkin's disease. Int J Cancer 1992;52:202-7
71. Brousset P, Rochaix P, Chittal S, Rubie H, Robert A, Delsol G. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large cell lymphoma in children. Histopathology 1993;23:189-91.
72. Filippa DA, Ladanyi M, Wollner N, et al. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 1996;87;2905-17.
73. Mason DY, Banks PM, Chan J, et al. Nodular lymphocyte predominance Hodgkin's disease: a distinct clinicopathological entity. Am J Surg Pathol 1994;18:526-30.
74. Delsol G, Blancher A, Al Saati T, et al: Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas. Br J Cancer 1994;64:321-6.
75. Al Saati T, Tkaczuk J, Krissansen G, et al. A novel antigen detected by the CBF.78 antibody further distinguishes anaplastic large cell lymphoma from Hodgkin's disease. Blood 1995;86: 2741-46.
76. Chittal SM, Delsol G. The interface between Hodgkin's disease and anaplastic large cell lymphoma. Cancer Surv 1997;30:87-105.
77. Caverivière P, Al Saati T, Voigt JJ, Delsol G. Diagnostic des tumeurs indifferenciees a l'aide d'anticorps monocloneaux. Press Med 1985;14:1691-5.
78. Gatter KC, Alcock C, Heyret A, Mason DY. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet 1985;1:1302-5.
79. Isaacson PG, O'Connor NTJ, Spencer J, et al. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet 1985;2: 688-91.
80. Telesinghe PU, Anthony PP. Primary lymphoma of the breast. Histopathology 1985;9:297-307.
81. Al Saati T, Caverivière P, Gorguet B, Delsol G, Gatter KC, Mason DY. Epithelial antigen in hematopoietic neoplasms [letter]. Hum Pathol 1986;17:533-4.
82. Norton AJ, Isaacson PG. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues. Histopathology 1986; 10:1243-60.
83. Salter DM, Krajewski AS, Dewar AE. Immunophenotype analysis of malignant histiocytosis of the intestine. J Clin Pathol 1986; 39:8-15.
84. Wick MR, Mills SE, Scheithauer BW, Cooper PH, Davitz MA, Parkinson K. Reassessment of malignant "angioendotheliomatosis": evidence in favour of reclassification as "intravascular lymphomatosis." Am J Surg Pathol 1986;10:112-23.
85. Bernier V, Azar HA. Filiform large-cell lymphomas: an ultrastructural and immunocytochemical study. Am J Surg Pathol 1987;11:387-96.
86. Gonzalez-Crussi F, Mangkornkanok M, Hsueh W. Large-cell lymphoma-diagnostic difficulties and case study. Am J Surg Pathol 1987;11:59-65.
87. Rabkin MS, Kjeldsberg CR. Epithelial membrane antigen staining patterns of histiocytic lesions. Arch Pathol Lab Med 1987; 111:337-8.
88. Faure P, Chittal S, Woodman-Memeteau F, et al. Diagnostic features of primary malignant lymphomas of the thyroid with monoclonal antibodies. Cancer 1988;61:1852-61.
89. Hall PA, D'Ardenne AJ, Stansfeld AG. Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma. Histopathology 1988;13:149-60.
90. Le Tourneau A, Audouin J, Diebold J. Ultrastructural study of 4 cases Ki-1 positive large anaplastic cell malignant lymphoma. Virchows Arch A Pathol Anat 1988;413:215-22.
91. Erlandson RA, Filippa DA. Unusual non-Hodgkin's lymphomas and true histiocytic lymphomas. Ultrastruct Pathol 1989;13: 249-73.
92. Kinney MC, Glick AD, Stein H, Collins RD. Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features. Am J Surg Pathol 1990;14:1047-60.
93. Mizukami Y, Michigishi T, Nonomura A, et al. Primary lymphoma of the thyroid: a clinical, histological and immunohistochemical study of 20 cases. Histopathology 1990;17:201-9.
94. Piris M, Brown DC, Gatter KC, Mason DY. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990;17:211-18.
95. Rivas C, Piris MA, Gamallo C, et al. Ultrastucture of 26 cases of Ki-1 lymphomas: morphoimmunologic correlation. Ultrastruct Pathol 1990;14:381-97.
96. Chittal SM, Brousset P, Voigt JJ, Delsol G. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 1991;19:211-20.
97. Delabie J, Vandenberghe E, Kennes C, et al. Histiocyte-rich B-cell lymphoma: a distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol 1992;16:37-48.
98. Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB. T-cell-rich B-cell lymphoma - a clinicopathologic study of 19 cases. Am J Surg Pathol 1992;16:351-63.
99. Suster S. Large cell lymphoma of mediastinum with marked tropism for germinal centers. Cancer 1992;69:2910-6.
100. Stroup R, Sheibani K. Antigenic phenotypes of hairy cell leukemia and monocytoid B-cell lymphoma: an immunohistochemical evaluation of 66 cases. Hum Pathol 1992;23:172-7.
101. Bateman AC, Wright DH. Epitheliotropism in high-grade lymphomas of mucosa-associated lymphoid tissue. Histopathology 1993;23:409-15.
102. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME. A small-cell-predominant variant of primary Ki-1 (CD30)± T-cell lymphoma. Am J Surg Pathol 1993;17:859-68.
103. Ohno T, Komada F, Yamaguchi M, et al. Gamma/delta T-cell lymphoma with hepatosplenomegaly: report of a case. Int J Hematol 1993;57:269-76.
104. Krishnan J, Wallberg K, Frizerra G. T-cell-rich large B-cell lymphoma: a study of 30 cases supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 1994;18: 455-65.
105. Kumar S, Kumar D, Schnadig VJ, Selvanayagam P, Slaughter DP. Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol 1994;102:633-9.
106. Raphael MM, Audouin J, Lamine M, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas: correlation with histologic features in 36 cases. Am J Clin Pathol 1994;101:773-82.
107. Brousset P, Chittal SM, Schlaifer D, Delosl G. T-cell rich B-cell lymphoma in the lung. Histopathology 1995;26:371-3.
108. Takeshita M, Akamatsu M, Ohshima K, et al. CD30 (Ki-1) expression in adult T-cell leukemia/lymphoma is associated with distinctive immunohistochemical and clinical characteristics. Histopathology 1995;26:539-46.
109. McBride JA, Ridriguez J, Luthra R, Ordonez NG, Cabanillas F, Pugh WC. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol 1996;20:193-201.
110. Lamant L, Meggetto F, Al Saati T, et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: comparison of cytogenetic analysis,reverse transcriptase-polymerase chain reaction and P80 immunostaining. Blood 1996;87:284-91.
111. Suster S, Moran CA. Pleomorphic large cell lymphomas of the mediastinum. Am J Surg Pathol 1996;20:224-32.
112. Delsol G, Lamant L, Mariamè B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 1997, 89: 1483-90.
113. Sibley R, Rosai J, Froehlich W. Comments by the panel. Ultrastruct Pathol 1985;8:369-73.
114. Schnitzer B, Roth MS, Hyder DM, Ginsburg D. Ki-1 lymphomas in children. Cancer 1988;61:1213-21.
115. Burns BF, Cripps C, Dardick D. A case of Ki-1 large cell lymphoma with ultrastructural features. Hum Pathol 1989;20:393-6.
116. Chan JKC, Ng CS, Hui PK, et al. Anaplastic large cell lymphoma: delineation of two morphologic types. Histopathology 1989;15: 11-34
117. Rimokh R, Magaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol 1989;71:31-7.
118. Kaneko Y, Frizzera G, Edamura S, et al. A novel translocation, t(2;5) (p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 1989;73:806-13.
119. Oka K, Mori N, Kojima M, Iijima T, Hanada T, Tsuchida M. Childhood Ki-1 lymphoma. Arch Pathol Lab Med 1989;113:998-1002.
120. Burns BF, Dardick I. Ki-1-positive non-Hodgkin's lymphomas An immunophenotypic, ultrastructural, and morphometric study. Am J Clin Pathol 1990;93:327-32.
121. Carbone A, Gloghini A, De Re V. Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens. Cancer 1990; 66:2547-56.
122. Chott A, Kasere K, Augustin I, et al. Ki-1-positive large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol 1990;14:439-48.
123. Le Tourneau A, Audouin J, Diebold J, Pujade-Lauraine E, Bernadou A. Large anaplastic cell Ki-1 positive malignant lymphoma with peculiar endocytotic vacuoles. Pathol Res Pract 1990;186:784-92.
124. Pileri S, Falini B, Delsol G, et al. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology 1990;16:383-91.
125. Rosso R, Paulli M, Magrini U, et al. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Virchows Arch A Pathol Anat 1990;416:229-35.
126. Banerjee SS, Heald J, Harris M. Twelve cases of Ki-1 positive anaplastic large cell lymphoma of skin. J Clin Pathol 1991;44: 119-25.
127. Chan JKC, Ng CS, Hui PK, et al. Anaplastic large cell Ki-1 lymphoma of bone. Cancer 1991;68:2186-91.
128. Gonzaaalez-Clemente JM, Ribera JM, Campo E, Bosch X, Monserrat E, Grau JM. Ki-1 anaplastic large cell lymphoma of T-cell origin in an HIV-infected patient. AIDS 1991;5:751-5.
129. Gustmann C, Altmannsberger M, Osborn M, Griesser H, Feller AC. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am J Pathol 1991;138:1413-22.
130. Pearson JM, Borg-Grech A. Primary Ki-1(CD30)-positive, large cell, anaplastic lymphoma of esophagus. Cancer 1991;68: 418-21.
131. Nakamura S, Takagi N, Kojima M, et al. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer 1991;68:118-29.
132. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS. Ki-1-positive large cell lymphomas, a heterogeneous group of neoplasms: morphologic, immunophenotypic, genotypic and clinical features of 24 cases. Cancer 1991;68:362-73.
133. Salhany KE, Collins RD, Greer JP, Kinney MC. Long-term survival in Ki-1 lymphoma. Cancer 1991;67:516-22.
134. Ornvold K, Carstensen H, Junge J, Gyhrs A, Ralfkiaer E. Tumours classified as "malignant histiocytosis" in children are T-cell neoplasms. APMIS 1992;100:558-66.
135. Perkins PL, Ross CW, Schnitzer B. CD30-positive anaplastic large-cell lymphomas that express CD15 but lack CD45: a possible diagnostic pitfall. Arch Pathol Lab Med 1992;116:1192-6.
136. Ross CW, Hanson CA, Schnitzer B. CD30 (Ki-1)-positive, anaplastic large cell lymphoma mimicking gastrointestinal carcinoma. Cancer 1992;70:2517-23.
137. de Bruin PC, Beljaards RC, van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 1993;23:127-35.
138. Mori N, Yatabe Y, Oka K, et al. Primary gastric Ki-1 positive anaplastic large cell lymphoma: a report of two cases. Pathol Int 1994;44:164-9.
139. Pileri S, Bocchia M, Baroni CD, et al. Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinicopathologic study of 69 cases. Br J Haematol 1994;86:513-23.
140. Rubie H, Gladieff L, Robert A, et al. Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases. Med Pediatr Oncol 1994;22:155-61.
141. Fraga M, Brousset P, Schlaifer D, et al. Bone marrow involvement in anaplastic large cell lymphoma. Am J Clin Pathol 1995; 103:82-9.
142. Havlioglu N, Manapelli A, Galindo L, Sotelo-Avila C, Grosso L. Primary Ki-1 (anaplastic large cell) lymphoma of the brain and spinal cord. Am J Clin Pathol 1995;103:496-9.
143. Ishizawa M, Okabe H, Matsumoto K, Hukuda S, Hodohara K, Ota S. Anaplastic large cell Ki-1 lymphoma with bone involvement: report of two cases. Virchows Arch 1995;427:105-10.
144. Mann KP, Hall B, Kamino H, Borowitz MJ, Ratech H. Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol 1995;19:406-17.
145. Morphopoulos G, Pitt MA, Bisset DL. Primary anaplastic large cell lymphoma of the rectum. Histopathology 1995;26:190-2.
146. Takeshita M, Ohshima K, Akamatsu M, et al. CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-1 endemic area. Hum Pathol 1995;26:614-9.
147. Xerri L, Parc P, Hassoun J, Birnbaum D. Molecular analysis of the NPM/ALK rearrangement in Hodgkin's disease. J Clin Pathol 1996;178:128-32.
148. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
149. DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996; 87:3437-11.
150. Morgan R, Smith SD, Hecht BK, et al. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(q23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 1989;73:2155-64.
151. Finn OJ, Jerome KR, Henderson RA, et al. MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 1995;145:61-89.